Bio-Kai significantly disrupts the Astaxanthin Market with BioOrganic Compound
August 1, 2021

REMONT, CALIFORNIA, US, July 13, 2021 / — CEOCFO Magazine, an independent business and investor publication that highlights important technologies and …

New Entrant Bio-Kai Plans to Disrupt Astaxanthin Market

Biomedican, a California-headquartered biotech company founded in 2017, known for its high-value compounds and cannabinoids (CBD), has entered the astaxanthin …

Fermentation specialist Biomedican to spin off astaxanthin unit
April 26, 2021

Fermentation specialist Biomedican plans to spin off a subsidiary that will be focused on astaxanthin production via a bioengineered yeast, …

Biomedican Enters the Global Astaxanthin Market Through Its Patented Biosynthesis Platform

SAN FRANCISCO, Dec. 2, 2020 /PRNewswire/ — BIOMEDICAN, a biotech company designing patented low-cost methods of growing high-value compounds at scale with proprietary …

How We Used Biosynthesis to Produce the World’s Strongest Antioxidant

In a recent article, “How We Used Biosynthesis to Produce the World’s Strongest Antioxidant,” published in Healthcare Business Today, Maxim …